# Phase 2A/B Efficacy and Safety of Dabogratinib in Participants With Low Grade Upper Tract Urothelial Carcinoma

> clinical trial · VERIFIED · 2026-07-01

Status: RECRUITING · Sponsor: Tyra Biosciences, Inc · Condition: Low Grade Upper Tract Urothelial Carcinoma

- Company: Tyra Biosciences, Inc
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT07265947

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.